Spots Global Cancer Trial Database for nk immunotherapy
Every month we try and update this database with for nk immunotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer | NCT02843581 | Metastatic Esop... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer | NCT02843815 | Non-small Cell ... | Cryosurgery NK Immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer | NCT02849340 | Recurrent Cervi... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer | NCT02843607 | Metastatic Rena... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors | NCT02843204 | Malignant Solid... | Pembrolizumab NK immunotherap... | 18 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma | NCT02849366 | Recurrent Adult... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer | NCT02843815 | Non-small Cell ... | Cryosurgery NK Immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors | NCT02853903 | Malignant Solid... | NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Rituximab and NK Immunotherapy for B Lymphoma | NCT02843061 | B-cell Lymphoma... | Rituximab NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver | NCT02849015 | Liver Tumor Evidence of Liv... | Cryosurgery NK immunotherap... | 30 Years - 60 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer | NCT02845856 | Recurrent Non-s... | Cetuximab NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors | NCT02843204 | Malignant Solid... | Pembrolizumab NK immunotherap... | 18 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer | NCT02844335 | Breast Cancer R... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer | NCT02849340 | Recurrent Cervi... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer | NCT02849379 | Recurrent Tongu... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors | NCT02857920 | Malignant Solid... | Bevacizumab NK immunotherap... | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer | NCT02849327 | Recurrent Phary... | Cryosurgery NK immunotherap... | 40 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors | NCT02843204 | Malignant Solid... | Pembrolizumab NK immunotherap... | 18 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer | NCT02849340 | Recurrent Cervi... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer | NCT02843126 | Recurrent Breas... | Trastuzumab NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer | NCT02849353 | Recurrent Ovari... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer | NCT03008343 | Recurrent Liver... | Irreversible El... Natural killer | 30 Years - 60 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer | NCT02844335 | Breast Cancer R... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer | NCT02849379 | Recurrent Tongu... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer | NCT02843581 | Metastatic Esop... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer | NCT02843802 | Secondary Malig... | Cryosurgery NK Immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer | NCT03008343 | Recurrent Liver... | Irreversible El... Natural killer | 30 Years - 60 Years | Fuda Cancer Hospital, Guangzhou | |
| Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors | NCT02857920 | Malignant Solid... | Bevacizumab NK immunotherap... | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
